Bridgewater Advisors Boosts Holdings in Amgen Inc.

Bridgewater Advisors Inc. significantly increased its holdings in Amgen Inc., purchasing an additional 2,914 shares of the medical research company's stock during the second quarter.

The fund owned 5,459 shares of Amgen's stock after buying more shares, valued at $2,064,000 by the end of the most recent reporting period. This represents a 114.5% boost in holdings compared to the previous quarter.

Amgen's stock performance has been strong, with the company's 52-week low being $269.77 and its 52-week high reaching $421.79. The firm has a market cap of $224.48 billion and a P/E ratio of 25.81.